Cysteamine bitartrate
( DrugBank: Cysteamine, Cysteamine bitartrate / KEGG DRUG: Cysteamine, Cysteamine hydrochloride, Cysteamine bitartrate, Cysteamine, Cysteamine hydrochloride, Cysteamine bitartrate )
4 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
8 | Huntington disease | 1 |
19 | Lysosomal storage disease | 18 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
21 | Mitochondrial disease | 2 |
299 | Cystic fibrosis | 5 |
8. Huntington disease
Clinical trials : 276 / Drugs : 185 - (DrugBank : 58) / Drug target genes : 86 - Drug target pathways : 160
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
19. Lysosomal storage disease
Clinical trials : 990 / Drugs : 584 - (DrugBank : 126) / Drug target genes : 62 - Drug target pathways : 192
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
21. Mitochondrial disease
Clinical trials : 94 / Drugs : 75 - (DrugBank : 31) / Drug target genes : 51 - Drug target pathways : 106
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
299. Cystic fibrosis
Clinical trials : 1,826 / Drugs : 1,271 - (DrugBank : 246) / Drug target genes : 118 - Drug target pathways : 180
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|